Clean Science and Technology Limited (CLEAN.NS)
- Previous Close
1,192.30 - Open
1,160.10 - Bid --
- Ask --
- Day's Range
1,160.00 - 1,197.90 - 52 Week Range
1,106.45 - 1,690.00 - Volume
71,379 - Avg. Volume
103,679 - Market Cap (intraday)
126.405B - Beta (5Y Monthly) -0.03
- PE Ratio (TTM)
48.43 - EPS (TTM)
24.56 - Earnings Date --
- Forward Dividend & Yield 5.00 (0.42%)
- Ex-Dividend Date Feb 7, 2025
- 1y Target Est
1,500.10
Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.
www.cleanscience.co.in457
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CLEAN.NS
View MorePerformance Overview: CLEAN.NS
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLEAN.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLEAN.NS
View MoreValuation Measures
Market Cap
126.34B
Enterprise Value
123.01B
Trailing P/E
48.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.79
Price/Book (mrq)
9.77
Enterprise Value/Revenue
13.39
Enterprise Value/EBITDA
29.46
Financial Highlights
Profitability and Income Statement
Profit Margin
28.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
9.3B
Net Income Avi to Common (ttm)
2.61B
Diluted EPS (ttm)
24.56
Balance Sheet and Cash Flow
Total Cash (mrq)
3.34B
Total Debt/Equity (mrq)
0.16%
Levered Free Cash Flow (ttm)
--